Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Anticancer dual VEGFR-2/3 and Flt3 kinase inhibitors active in preclinical models

Sep. 10, 2008

Five Prime initiates phase I FP-1039 trial in advanced solid tumors

Sep. 10, 2008

Palifosfamide studied in new phase II trial for soft tissue sarcoma

Sep. 9, 2008

Ardea Biosciences describes discovery of MEK inhibitor RDEA-119

Sep. 9, 2008

First-in-class inhibitors of EWS-FLI1 protein potentially effective against Ewing's sarcoma

Sep. 9, 2008

Indomethacin silicon-amide derivatives may have improved physiological activity

Sep. 9, 2008

Debiopharm and EPFL initiate research project Debio 0826 in cancer

Sep. 8, 2008

Nuclear orphan receptor Nur77 can be targeted with cytosporone B

Sep. 8, 2008

Celator receives FDA orphan drug designation for anticancer agent CPX-351

Sep. 5, 2008

ImClone submits sBLA for Erbitux in first-line head and neck cancer

Sep. 5, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...